Researchers identify stem cell–based molecular subtypes that improve prognosis prediction in colorectal cancer and support ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...

A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of ...

Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP ...

Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...

A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of ...

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to invest in. On December 8, Sana ...

NewcelX ( ($NCEL) ) has provided an update. On January 5, 2026, NewcelX Ltd. announced the appointment of Dr. Julien Boisdron, a veteran diabetes ...

U.S. Patent No. 12,496,316, entitled “Treatment of Sexual Dysfunction and Improvement in Sexual Quality of Life,” provides Longeveron with patent rights in the United States through 2038. Further ...

Longer-term results from the BENEFIT trial show sustained minimal residual disease negativity in newly diagnosed, ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...